Perspective Therapeutics, Inc. — Director's Dealing 2019

Nov 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2019-11-14

Reporting Person: Woods Lori A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-14	Common Stock	P	125000	$0.39640	Acquired	255000	Direct
2019-11-15	Common Stock	P	25000	$0.3898	Acquired	280000	Direct